Swiss medtech startup Medyria AG has raised CHF 1.5 million from Buenavista to support the PyCath catheter system's development and expand its international operations.

Target Information

Medyria AG is a Swiss medtech startup that specializes in the development of innovative medical technologies, particularly its flagship product, the PyCath catheter system. The company has recently secured CHF 1.5 million in a funding round led by Buenavista, a venture capital firm based in Lisbon. These funds will play a crucial role in advancing Medyria's development efforts, particularly as it prepares to move forward with its first-in-human clinical trial.

The PyCath system represents a significant advancement in catheter technology, aiming to improve patient outcomes in various medical procedures. As Medyria progresses with its clinical studies and regulatory submissions, it is gearing up to make a substantial impact in the medical device market, particularly in the United States.

Industry Overview in Switzerland

The medical technology industry in Switzerland is renowned for its innovation and quality, positioning the country as a global leader in medtech advancements. Swiss medtech companies benefit from a strong research and de